maslinic acid has been researched along with Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YH; Hung, HY | 1 |
| Claro-Cala, CM; de Sotomayor, MA; Herrera, MD; Miñano, J; Pérez-Montero, M; Quintela, JC; Rodríguez-Rodríguez, AR | 1 |
| Dai, YW; Fang, LW; Huang, WC; Liou, CJ; Wang, CL | 1 |
1 review(s) available for maslinic acid and Obesity
| Article | Year |
|---|---|
Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
Topics: Animals; Anti-Obesity Agents; Drug Discovery; Obesity; Phytochemicals | 2022 |
2 other study(ies) available for maslinic acid and Obesity
| Article | Year |
|---|---|
Pomace Olive Oil Concentrated in Triterpenic Acids Restores Vascular Function, Glucose Tolerance and Obesity Progression in Mice.
Topics: Adiposity; Animals; Aorta, Thoracic; Biomarkers; Blood Glucose; Diet, High-Fat; Diet, Mediterranean; Disease Models, Animal; Disease Progression; Insulin Resistance; Male; Mice, Inbred C57BL; Obesity; Oleanolic Acid; Olive Oil; Triterpenes; Vasoconstriction; Vasodilation; Weight Gain | 2020 |
Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Protective Agents; Signal Transduction; Triterpenes | 2019 |